Clinical trial
Apathy Associated With Alzheimer's Disease
NCT00254033 · Sunnybrook Health Sciences Centre, Other · Completed
Key facts
| NCT number | NCT00254033 |
|---|---|
| Title | Apathy Associated With Alzheimer's Disease |
| Official title | The Role of the Dopaminergic Brain Reward System in Apathy Associated With Alzheimer's Disease |
| Lead sponsor | Sunnybrook Health Sciences Centre, Other |
| Collaborators | American Health Assistance Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dementia, Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Dextroamphetamine, Methylphenidate |
| Enrollment | 40 |
| Start date | Oct 1, 2003 |
| Completion | Oct 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Apr 28, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: